Enter the first few characters of Company and click 'Go'
Audited Results of Suven Life Sciences Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
13.54 |
11.84 |
13.48 |
14.41 |
285.67 |
Manufacturing Expenses |
0 |
0 |
0 |
0 |
48.14 |
Personnel Expenses |
15.77 |
17.46 |
15.29 |
14.60 |
33.85 |
Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Administrative Expenses |
25.51 |
31.02 |
28.74 |
35.08 |
84.10 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
41.28 |
48.49 |
44.03 |
49.68 |
236.97 |
Operating Profit |
-27.74 |
-36.64 |
-30.55 |
-35.26 |
48.70 |
Other Recurring Income |
8.45 |
5.32 |
7.75 |
14.04 |
27.25 |
Adjusted PBDIT |
-19.29 |
-31.33 |
-22.79 |
-21.23 |
75.95 |
Financial Expenses |
0.29 |
0.53 |
0.82 |
0.54 |
1.90 |
Depreciation |
6.54 |
4.39 |
4.35 |
4.17 |
10.79 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
-26.13 |
-36.25 |
-27.95 |
-25.94 |
63.25 |
Tax Charges |
0 |
0 |
-5.32 |
-12.18 |
24.06 |
Adjusted PAT |
-26.13 |
-36.25 |
-22.63 |
-13.75 |
39.19 |
Non Recurring Items |
6.19 |
-0.15 |
-0.31 |
-0.30 |
-0.14 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
-20.13 |
-36.25 |
-22.63 |
-13.75 |
39.19 |
Equity Dividend |
0 |
0 |
0 |
0 |
0 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
141.49 |
161.43 |
197.83 |
220.77 |
554.54 |